MR3 Health is a dynamic company bringing an innovative combination of service and preventive technology to patients and insurers to assist in dealing with diabetic foot issues, while reducing the cost of healthcare. Although we are a young company, MR3 Health is uniquely positioned for success with a number of resources unknown to most start-ups. These include issued patents, an FDA cleared medical device supported by clinical trials, and a management team with a wealth of business, manufacturing and medical experience.
Every 30 seconds worldwide someone with diabetes suffers an amputation. Diabetic neuropathy leads to nerve damage and loss of sensation in the sole of the foot while inflammation leads to undetected pressure ulcers. In the U.S., about 80 percent of lower limb amputations started off as a diabetic foot ulcer.
Without early detection and treatment, ulcers become infected frequently leading to full or partial amputation of the foot or lower limb.
According to the American Diabetes Association, approximately 700,000 diabetics in the U.S. will experience a foot ulcer annually. While approximately 73,000 diabetics will experience a lower extremity amputation annually. Medical claims for these procedures will total $3.7 billion.
Most significantly, the life expectancy of a diabetic amputee is less than five years.